Drugmaker Kowa, Israel's Teva plan joint generic drug firm

Drugmaker Kowa, Israel's Teva plan joint generic drug firm

TOKYO, Japan - Shlomo Yanai (L), president and chief executive officer of Israel's Teva Pharmaceutical Industries Ltd., and Yoshihiro Miwa, president of Japanese drugmaker Kowa Co., shake hands during a press conference in Tokyo on Sept. 24 at which they announced the two companies will set up a joint generic drug company in Tokyo next year. (Kyodo)

  • Product Code
  • ILEA000040088
  • Registered date
  • 2008/9/24 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1303 × 1364 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 513.72(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    ITOCHU Corporation's acquisition of Bic Motor, Inc. and establishment of a new company, WECARS

    ITOCHU Corporation's acquisition of Bic Motor, Inc. and establishment of a new company, WECARS

    ITOCHU Corporation acquires Bic Motor Co. Press conference on the establishment of the new company, WECARS. Pictured from right to left: Masatoshi Maki, ITOCHU Corporation Executive Officer; Shinjiro Tanaka, President and CEO of WECARS; Tsutomu Yamauchi, Executive Vice President and COO of WECARS; and Wataru Goroku, General Manager of Corporate Planning Department of WECARS. ＝May 1, 2024, in Tokyo
      ITOCHU Corporation's acquisition of Bic Motor and establishment of a new company, WECARS

      ITOCHU Corporation's acquisition of Bic Motor and establishment of a new company, WECARS

      ITOCHU Corporation acquired Bic Motor Co. Press conference on the establishment of the new company, WECARS. (Photo from right to left: Masatoshi Maki, Executive Officer of ITOCHU Corporation; Shinjiro Tanaka, President and CEO of WECARS; and Tsutomu Yamauchi, Executive Vice President and COO of WECARS) = May 1, 2024, in Tokyo.

        Scandal-ridden Bigmotor reborn as new firm

        TOKYO, Japan, May 1 Kyodo - Shinjiro Tanaka (C), president of Wecars, a new firm that took over the troubled used car dealership Bigmotor Co.'s main businesses, poses at a press conference in Tokyo on May 1, 2024. The president vowed to make Wecars' operations transparent following the high-profile insurance fraud scandal, as it runs about 250 outlets with a workforce of 4,200. (Kyodo)

          [Breaking News] OpenAI sets up first Asian base in Tokyo

          TOKYO, Japan, April 15 Kyodo - Brad Lightcap, chief operating officer of OpenAI, the developer of generative artificial intelligence tool ChatGPT, holds a press conference in Tokyo on April 15, 2024, after the San Francisco-based company launched its first Asian base in Tokyo. (Kyodo)
            Daihatsu unveils new management policy after testing scandal

            Daihatsu unveils new management policy after testing scandal

            Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. ==Kyodo

              Daihatsu unveils new management policy after testing scandal

              TOKYO, Japan, April 8 Kyodo - Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. (Kyodo)
                Kobayashi Pharmaceutical dietary pills scandal

                Kobayashi Pharmaceutical dietary pills scandal

                Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                  Kobayashi Pharmaceutical dietary pills scandal

                  Kobayashi Pharmaceutical dietary pills scandal

                  Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                    Kobayashi Pharmaceutical dietary pills scandal

                    Kobayashi Pharmaceutical dietary pills scandal

                    Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                      Kobayashi Pharmaceutical dietary pills scandal

                      Kobayashi Pharmaceutical dietary pills scandal

                      Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.